ZA200901912B - Use of human cells of myeloid leukaemia origin for expression of antibodies - Google Patents

Use of human cells of myeloid leukaemia origin for expression of antibodies

Info

Publication number
ZA200901912B
ZA200901912B ZA200901912A ZA200901912A ZA200901912B ZA 200901912 B ZA200901912 B ZA 200901912B ZA 200901912 A ZA200901912 A ZA 200901912A ZA 200901912 A ZA200901912 A ZA 200901912A ZA 200901912 B ZA200901912 B ZA 200901912B
Authority
ZA
South Africa
Prior art keywords
antibodies
expression
human cells
myeloid leukaemia
leukaemia origin
Prior art date
Application number
ZA200901912A
Inventor
Steffen Goletz
Antje Danielczyk
Hans Baumeister
Renate Stahn
Anja Loeffler
Lars Stoeckl
Original Assignee
Glycotope Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycotope Gmbh filed Critical Glycotope Gmbh
Publication of ZA200901912B publication Critical patent/ZA200901912B/en

Links

ZA200901912A 2006-09-10 2007-09-10 Use of human cells of myeloid leukaemia origin for expression of antibodies ZA200901912B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06090162 2006-09-10

Publications (1)

Publication Number Publication Date
ZA200901912B true ZA200901912B (en) 2010-06-30

Family

ID=41372696

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200901912A ZA200901912B (en) 2006-09-10 2007-09-10 Use of human cells of myeloid leukaemia origin for expression of antibodies

Country Status (2)

Country Link
CN (1) CN101588817B (en)
ZA (1) ZA200901912B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140296490A1 (en) * 2011-08-10 2014-10-02 Laboratoire Français Du Fractionnement Et Des Biotechnologies Highly galactosylated antibodies
EP2956480B1 (en) * 2013-02-13 2019-09-04 Laboratoire Français du Fractionnement et des Biotechnologies Highly galactosylated anti-tnf-alpha antibodies and uses thereof
BR112015019348A2 (en) 2013-02-13 2017-08-22 Lab Francais Du Fractionnement METHODS FOR PRODUCING GLYCOSYLATION MODIFIED AND SIALYLATION ENHANCED PROTEIN, TO ENHANCE SIALYL TRANSFERASE ACTIVITY IN THE MAMMARY GLAND AND TO PRODUCE SIALYL TRANSFERASE, GLYCOSYLATION MODIFIED PROTEIN OR SIALYLATION ENHANCED PROTEIN, COMPOSITION, SIALYL TRANSFERASE, MAMMALIAN, AND TRANSGENE MAMMARY EPITHELIAL
TW201444870A (en) * 2013-02-13 2014-12-01 Lab Francais Du Fractionnement Highly galactosylated anti-HER2 antibodies and uses thereof
CN107987160A (en) 2016-10-26 2018-05-04 无锡科捷诺生物科技有限责任公司 A kind of monoclonal antibody of no fucosylation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60039596D1 (en) * 1999-03-30 2008-09-04 Japan Tobacco Inc PROCESS FOR THE PREPARATION OF MONOCLONAL ANTIBODIES

Also Published As

Publication number Publication date
CN101588817A (en) 2009-11-25
CN101588817B (en) 2013-06-12

Similar Documents

Publication Publication Date Title
FI2073842T4 (en) Use of human cells of myeloid leukaemia origin for expression of antibodies
HRP20181616T1 (en) Fully human anti-vap-1 monoclonal antibodies
HK1223114A1 (en) Anti-factor xi monoclonal antibodies and methods of use thereof xi
EP2115664A4 (en) Quantitative analysis of skin characteristics
IL193604A0 (en) Methods of using antibodies against human il-22
SI2949666T1 (en) Human anti-alpha-synuclein antibodies
HK1150839A1 (en) Compositions and methods of use for therapeutic antibodies
IL196701A0 (en) HUMAN ANTIBODIES TO ErbB2
IL200610A (en) Human monoclonal anti-ip-10 antibodies and uses thereof
EP2109625A4 (en) Use of antibody conjugates
EP2207803A4 (en) Cd9-specific human antibodies
HK1108614A1 (en) Human body composition analyzer
IL212795A0 (en) Fully human antibodies against n-cadherin
HK1128237A1 (en) Further medical uses of antisecretory protein
ZA200901912B (en) Use of human cells of myeloid leukaemia origin for expression of antibodies
EP2086592A4 (en) Weakly basic 2- nitroimidazoles for the non-invasive detection of tissue hypoxia
HRP20190159T1 (en) Human anti-alpha-synuclein antibodies
HU0700076V0 (en) Device for covered introduction of scalpels
TWM300387U (en) Improved structure of cupulate holder